The Steroid-Corticosteroids Market is expected to register a CAGR of 4.5% from 2025 to 2031, with a market size expanding from US$ XX Million in 2024 to US$ XX Million by 2031.
The research report on the Steroid-Corticosteroids Market is segmented by product type into glucocorticoids, mineralocorticoids, and combination formulations. Applications analyzed include inflammatory diseases, autoimmune disorders, respiratory conditions, dermatological treatments, and musculoskeletal disorders. End-users include hospitals, specialty clinics, research laboratories, and pharmaceutical companies. The regional analysis covers key markets such as North America, Europe, Asia Pacific, the Middle East and Africa, and South America. The market evaluation is presented in US$ for all segmental analyses.
Purpose of the ReportThe report Steroid-Corticosteroids Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Steroid-Corticosteroids Market Segmentation
Type- Cream
- Injection
- Glucocorticoids
- Mineralocorticoids
- Hospitals
- Clinics
Strategic Insights
Steroid-Corticosteroids Market Growth Drivers- Increasing Prevalence of Chronic Diseases: One of the foremost reasons fuelling the steroid-corticosteroids market is the ever-increasing prevalence of chronic inflammatory and autoimmune diseases like asthma, arthritis, and IBD; these diseases necessitate a long-term treatment regimen that necessitates the use of corticosteroids to manage inflammation, pain, and immune responses. Demand for corticosteroid drugs is rising to manage chronic diseases as the world's aged population grows. The increasing diagnosis of conditions like COPD and dermatological diseases is pushing the market even more.
- Awareness of Steroid-Based Treatments on the Rise: The rise of awareness raised on steroid-based treatments, especially their role in treating allergies, asthma, and autoimmune disorders, is the market growth. The corticosteroid therapy has very much firmly reached everyday life, thanks to further awareness raised among the patients after they have entered the system regarding the corticosteroids, which are used to treat these conditions. Furthermore, awareness campaigns and physician education on the proper administration of corticosteroids will assuage fears over their side effects and make their more comfortable use by patients a welcome development. The riding realization is prevalent in the case of developed nations, which, besides having a sort of awareness regarding the treatment options, are also arms in terms of access to healthcare and pharmaceutical products.
- Advancements in Drug Delivery Systems: The innovations triggered in drug delivery systems for corticosteroids, whether they be inhalers, topical applications, or controlled-release formulas, are augmenting the effectiveness as well as the comfort associated with steroid-based treatments. Through these innovations aimed towards a local area on the body, the side effects are fewer and allow for localized treatment while minimizing systemic exposure. The development of inhaled corticosteroids for asthma and COPD, for example, has provided much more individualized treatment for millions of sufferers and thus, improved the quality of life for those patients. These developments also lend valuable support for the requirement of longer-term treatment regimens, which are highly desirable for chronic disease states.
- Long-Acting and Extended-Release Formulations:
A major development in the corticosteroid market pertains to the long-acting and extended-release formulation products. These formulations will lead to lower daily doses required for treatment, allowing improved patient adherence and convenience. The use of long-acting corticosteroids, like long-acting beta-agonists with corticosteroids for respiratory conditions, is being borne to the treatment of asthma and COPD. The increase in the development and use of this kind of formulation is expected to increase with a prolonged rise in the global burden of chronic diseases. This trend is consistent with a gradual shift towards more convenient treatment options in chronic disease management.
- Personalised Medicine and Biologic Combination:
Personalised medicine is emerging as a significant trend in the corticosteroid market regarding autoimmune diseases and inflammatory conditions. The advancing genetic tests and ongoing biomarker research has now allowed healthcare providers to tailor corticosteroid treatments specifically based on an individual patient's genetic makeup and severity of disease. Moreover, the use of corticosteroids is also increasingly being considered along with biologic therapies in rheumatoid arthritis, Crohn's disease, and psoriasis; this combination therapy approach allows exploiting the best pros offered through both classes of drugs, targeting different aspects of the immune system and inflammation, which has become a growing trend in the management of complex conditions. - Increased Usage of Corticosteroids in Dermatology Applications:
Corticosteroids are used in dermatology for numerous types of inflammatory skin conditions, including eczema, psoriasis, and dermatitis. The steroid-corticosteroid market exhibits an increasing tendency to provide new topical corticosteroid formulations-a variety of creams, ointments, and gels-that have greater efficacy and less potential for systemic side effects. The increased incidences of skin conditions, with a particular emphasis on the aging population, will further provide an impetus for the growth in dermatological treatment by corticosteroids. The trend also covers innovations like dual-purpose creams offering both steroidal and non-steroidal treatments.
- Expanding Applications in Respiratory Diseases: The steroid-corticosteroid market presents significant growth opportunities in the management of respiratory diseases, particularly asthma and COPD. The increasing incidence of asthma, especially in children, and the rising number of elderly people with COPD are driving demand for corticosteroid-based therapies. The market for inhaled corticosteroids (ICS) is expected to continue growing due to their targeted delivery and high efficacy in managing respiratory conditions. Opportunities for growth exist in improving drug delivery systems, such as creating more efficient inhalers, dry powder inhalers (DPIs), and nebulizer solutions for better patient outcomes.
- Increasing Focus on Steroid-Sparing Therapies:
Although corticosteroids are highly effective, their long-term use is often associated with side effects, such as osteoporosis, weight gain, and increased risk of infections. As a result, there is a growing focus on steroid-sparing therapies, particularly in conditions like rheumatoid arthritis, lupus, and Crohn’s disease. The development of alternative therapies that reduce reliance on corticosteroids presents an opportunity for innovation within the market. Steroid-sparing biologic therapies and disease-modifying anti-rheumatic drugs (DMARDs) are gaining traction, and their integration with corticosteroids can offer patients safer treatment options with fewer adverse effects. - Targeted Steroid Therapy for Cancer Treatment: There is an emerging opportunity for corticosteroids in oncology, particularly in combination therapies for cancer. Steroids are frequently used as part of chemotherapy regimens to reduce inflammation and suppress the immune system in certain cancers, such as lymphoma and leukemia. They can also alleviate some chemotherapy-induced side effects like nausea and pain. As cancer treatments become more personalized, the role of corticosteroids in supportive cancer care is likely to expand. Developing new steroid-based therapies that are optimized for oncology patients could drive growth in this niche area of the steroid-corticosteroid market.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Steroid-Corticosteroids Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Steroid-Corticosteroids Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The Steroid-Corticosteroids Market is expected to register a CAGR of 4.5% from 2025-2031.
The major driving factors supporting the Steroid-Corticosteroids Market growth are- Increasing Prevalence of Chronic Diseases and Awareness of Steroid-Based Treatments on the Rise
Key Future Trends in the Steroid-Corticosteroids Market are- Long-Acting and Extended-Release Formulations and Personalised Medicine and Biologic Combination
Key companies in the Steroid-Corticosteroids Market are - GlaxoSmithKline plc, Novartis, AstraZeneca, Cipla, Merck & Co., Inc., Sumitomo Corporation, Johnson and Johnson, Pfizer Inc., Sanofi
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
1.INTRODUCTION
1.1.SCOPE OF THE STUDY
1.2.THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3.MARKET SEGMENTATION
1.3.1Steroid-Corticosteroids Market - By Type
1.3.2Steroid-Corticosteroids Market - By Class
1.3.3Steroid-Corticosteroids Market - By End-user
1.3.4Steroid-Corticosteroids Market - By Region
1.3.4.1By Country
2.KEY TAKEAWAYS
3.RESEARCH METHODOLOGY
4.STEROID-CORTICOSTEROIDS MARKET LANDSCAPE
4.1.OVERVIEW
4.2.PEST ANALYSIS
4.2.1North America - Pest Analysis
4.2.2Europe - Pest Analysis
4.2.3Asia-Pacific - Pest Analysis
4.2.4Middle East and Africa - Pest Analysis
4.2.5South and Central America - Pest Analysis
4.3.EXPERT OPINIONS
5.STEROID-CORTICOSTEROIDS MARKET - KEY MARKET DYNAMICS
5.1.KEY MARKET DRIVERS
5.2.KEY MARKET RESTRAINTS
5.3.KEY MARKET OPPORTUNITIES
5.4.FUTURE TRENDS
5.5.IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6.STEROID-CORTICOSTEROIDS MARKET - GLOBAL MARKET ANALYSIS
6.1.STEROID-CORTICOSTEROIDS - GLOBAL MARKET OVERVIEW
6.2.STEROID-CORTICOSTEROIDS - GLOBAL MARKET AND FORECAST TO 2028
6.3.MARKET POSITIONING/MARKET SHARE
7.STEROID-CORTICOSTEROIDS MARKET - REVENUE AND FORECASTS TO 2028 â" TYPE
7.1.OVERVIEW
7.2.TYPE MARKET FORECASTS AND ANALYSIS
7.3.CREAM
7.3.1.Overview
7.3.2.Cream Market Forecast and Analysis
7.4.INJECTION
7.4.1.Overview
7.4.2.Injection Market Forecast and Analysis
7.5.OTHERS
7.5.1.Overview
7.5.2.Others Market Forecast and Analysis
8.STEROID-CORTICOSTEROIDS MARKET - REVENUE AND FORECASTS TO 2028 â" CLASS
8.1.OVERVIEW
8.2.CLASS MARKET FORECASTS AND ANALYSIS
8.3.GLUCOCORTICOIDS. MINERALOCORTICOIDS
8.3.1.Overview
8.3.2.Glucocorticoids. Mineralocorticoids Market Forecast and Analysis
9.STEROID-CORTICOSTEROIDS MARKET - REVENUE AND FORECASTS TO 2028 â" END-USER
9.1.OVERVIEW
9.2.END-USER MARKET FORECASTS AND ANALYSIS
9.3.HOSPITALS
9.3.1.Overview
9.3.2.Hospitals Market Forecast and Analysis
9.4.CLINICS
9.4.1.Overview
9.4.2.Clinics Market Forecast and Analysis
9.5.OTHERS
9.5.1.Overview
9.5.2.Others Market Forecast and Analysis
10.STEROID-CORTICOSTEROIDS MARKET REVENUE AND FORECASTS TO 2028 â" GEOGRAPHICAL ANALYSIS
10.1.NORTH AMERICA
10.1.1North America Steroid-Corticosteroids Market Overview
10.1.2North America Steroid-Corticosteroids Market Forecasts and Analysis
10.1.3North America Steroid-Corticosteroids Market Forecasts and Analysis - By Type
10.1.4North America Steroid-Corticosteroids Market Forecasts and Analysis - By Class
10.1.5North America Steroid-Corticosteroids Market Forecasts and Analysis - By End-user
10.1.6North America Steroid-Corticosteroids Market Forecasts and Analysis - By Countries
10.1.6.1United States Steroid-Corticosteroids Market
10.1.6.1.1United States Steroid-Corticosteroids Market by Type
10.1.6.1.2United States Steroid-Corticosteroids Market by Class
10.1.6.1.3United States Steroid-Corticosteroids Market by End-user
10.1.6.2Canada Steroid-Corticosteroids Market
10.1.6.2.1Canada Steroid-Corticosteroids Market by Type
10.1.6.2.2Canada Steroid-Corticosteroids Market by Class
10.1.6.2.3Canada Steroid-Corticosteroids Market by End-user
10.1.6.3Mexico Steroid-Corticosteroids Market
10.1.6.3.1Mexico Steroid-Corticosteroids Market by Type
10.1.6.3.2Mexico Steroid-Corticosteroids Market by Class
10.1.6.3.3Mexico Steroid-Corticosteroids Market by End-user
10.2.EUROPE
10.2.1Europe Steroid-Corticosteroids Market Overview
10.2.2Europe Steroid-Corticosteroids Market Forecasts and Analysis
10.2.3Europe Steroid-Corticosteroids Market Forecasts and Analysis - By Type
10.2.4Europe Steroid-Corticosteroids Market Forecasts and Analysis - By Class
10.2.5Europe Steroid-Corticosteroids Market Forecasts and Analysis - By End-user
10.2.6Europe Steroid-Corticosteroids Market Forecasts and Analysis - By Countries
10.2.6.1Germany Steroid-Corticosteroids Market
10.2.6.1.1Germany Steroid-Corticosteroids Market by Type
10.2.6.1.2Germany Steroid-Corticosteroids Market by Class
10.2.6.1.3Germany Steroid-Corticosteroids Market by End-user
10.2.6.2France Steroid-Corticosteroids Market
10.2.6.2.1France Steroid-Corticosteroids Market by Type
10.2.6.2.2France Steroid-Corticosteroids Market by Class
10.2.6.2.3France Steroid-Corticosteroids Market by End-user
10.2.6.3Italy Steroid-Corticosteroids Market
10.2.6.3.1Italy Steroid-Corticosteroids Market by Type
10.2.6.3.2Italy Steroid-Corticosteroids Market by Class
10.2.6.3.3Italy Steroid-Corticosteroids Market by End-user
10.2.6.4Spain Steroid-Corticosteroids Market
10.2.6.4.1Spain Steroid-Corticosteroids Market by Type
10.2.6.4.2Spain Steroid-Corticosteroids Market by Class
10.2.6.4.3Spain Steroid-Corticosteroids Market by End-user
10.2.6.5United Kingdom Steroid-Corticosteroids Market
10.2.6.5.1United Kingdom Steroid-Corticosteroids Market by Type
10.2.6.5.2United Kingdom Steroid-Corticosteroids Market by Class
10.2.6.5.3United Kingdom Steroid-Corticosteroids Market by End-user
10.3.ASIA-PACIFIC
10.3.1Asia-Pacific Steroid-Corticosteroids Market Overview
10.3.2Asia-Pacific Steroid-Corticosteroids Market Forecasts and Analysis
10.3.3Asia-Pacific Steroid-Corticosteroids Market Forecasts and Analysis - By Type
10.3.4Asia-Pacific Steroid-Corticosteroids Market Forecasts and Analysis - By Class
10.3.5Asia-Pacific Steroid-Corticosteroids Market Forecasts and Analysis - By End-user
10.3.6Asia-Pacific Steroid-Corticosteroids Market Forecasts and Analysis - By Countries
10.3.6.1Australia Steroid-Corticosteroids Market
10.3.6.1.1Australia Steroid-Corticosteroids Market by Type
10.3.6.1.2Australia Steroid-Corticosteroids Market by Class
10.3.6.1.3Australia Steroid-Corticosteroids Market by End-user
10.3.6.2China Steroid-Corticosteroids Market
10.3.6.2.1China Steroid-Corticosteroids Market by Type
10.3.6.2.2China Steroid-Corticosteroids Market by Class
10.3.6.2.3China Steroid-Corticosteroids Market by End-user
10.3.6.3India Steroid-Corticosteroids Market
10.3.6.3.1India Steroid-Corticosteroids Market by Type
10.3.6.3.2India Steroid-Corticosteroids Market by Class
10.3.6.3.3India Steroid-Corticosteroids Market by End-user
10.3.6.4Japan Steroid-Corticosteroids Market
10.3.6.4.1Japan Steroid-Corticosteroids Market by Type
10.3.6.4.2Japan Steroid-Corticosteroids Market by Class
10.3.6.4.3Japan Steroid-Corticosteroids Market by End-user
10.3.6.5South Korea Steroid-Corticosteroids Market
10.3.6.5.1South Korea Steroid-Corticosteroids Market by Type
10.3.6.5.2South Korea Steroid-Corticosteroids Market by Class
10.3.6.5.3South Korea Steroid-Corticosteroids Market by End-user
10.4.MIDDLE EAST AND AFRICA
10.4.1Middle East and Africa Steroid-Corticosteroids Market Overview
10.4.2Middle East and Africa Steroid-Corticosteroids Market Forecasts and Analysis
10.4.3Middle East and Africa Steroid-Corticosteroids Market Forecasts and Analysis - By Type
10.4.4Middle East and Africa Steroid-Corticosteroids Market Forecasts and Analysis - By Class
10.4.5Middle East and Africa Steroid-Corticosteroids Market Forecasts and Analysis - By End-user
10.4.6Middle East and Africa Steroid-Corticosteroids Market Forecasts and Analysis - By Countries
10.4.6.1South Africa Steroid-Corticosteroids Market
10.4.6.1.1South Africa Steroid-Corticosteroids Market by Type
10.4.6.1.2South Africa Steroid-Corticosteroids Market by Class
10.4.6.1.3South Africa Steroid-Corticosteroids Market by End-user
10.4.6.2Saudi Arabia Steroid-Corticosteroids Market
10.4.6.2.1Saudi Arabia Steroid-Corticosteroids Market by Type
10.4.6.2.2Saudi Arabia Steroid-Corticosteroids Market by Class
10.4.6.2.3Saudi Arabia Steroid-Corticosteroids Market by End-user
10.4.6.3U.A.E Steroid-Corticosteroids Market
10.4.6.3.1U.A.E Steroid-Corticosteroids Market by Type
10.4.6.3.2U.A.E Steroid-Corticosteroids Market by Class
10.4.6.3.3U.A.E Steroid-Corticosteroids Market by End-user
10.4.6.4Rest of Middle East and Africa Steroid-Corticosteroids Market
10.4.6.4.1Rest of Middle East and Africa Steroid-Corticosteroids Market by Type
10.4.6.4.2Rest of Middle East and Africa Steroid-Corticosteroids Market by Class
10.4.6.4.3Rest of Middle East and Africa Steroid-Corticosteroids Market by End-user
10.5.SOUTH AND CENTRAL AMERICA
10.5.1South and Central America Steroid-Corticosteroids Market Overview
10.5.2South and Central America Steroid-Corticosteroids Market Forecasts and Analysis
10.5.3South and Central America Steroid-Corticosteroids Market Forecasts and Analysis - By Type
10.5.4South and Central America Steroid-Corticosteroids Market Forecasts and Analysis - By Class
10.5.5South and Central America Steroid-Corticosteroids Market Forecasts and Analysis - By End-user
10.5.6South and Central America Steroid-Corticosteroids Market Forecasts and Analysis - By Countries
10.5.6.1Brazil Steroid-Corticosteroids Market
10.5.6.1.1Brazil Steroid-Corticosteroids Market by Type
10.5.6.1.2Brazil Steroid-Corticosteroids Market by Class
10.5.6.1.3Brazil Steroid-Corticosteroids Market by End-user
10.5.6.2Argentina Steroid-Corticosteroids Market
10.5.6.2.1Argentina Steroid-Corticosteroids Market by Type
10.5.6.2.2Argentina Steroid-Corticosteroids Market by Class
10.5.6.2.3Argentina Steroid-Corticosteroids Market by End-user
10.5.6.3Rest of South and Central America Steroid-Corticosteroids Market
10.5.6.3.1Rest of South and Central America Steroid-Corticosteroids Market by Type
10.5.6.3.2Rest of South and Central America Steroid-Corticosteroids Market by Class
10.5.6.3.3Rest of South and Central America Steroid-Corticosteroids Market by End-user
11.INDUSTRY LANDSCAPE
11.1.MERGERS AND ACQUISITIONS
11.2.AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3.NEW PRODUCT LAUNCHES
11.4.EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12.STEROID-CORTICOSTEROIDS MARKET, KEY COMPANY PROFILES
12.1.GLAXOSMITHKLINE PLC
12.1.1.Key Facts
12.1.2.Business Description
12.1.3.Products and Services
12.1.4.Financial Overview
12.1.5.SWOT Analysis
12.1.6.Key Developments
12.2.NOVARTIS
12.2.1.Key Facts
12.2.2.Business Description
12.2.3.Products and Services
12.2.4.Financial Overview
12.2.5.SWOT Analysis
12.2.6.Key Developments
12.3.ASTRAZENECA
12.3.1.Key Facts
12.3.2.Business Description
12.3.3.Products and Services
12.3.4.Financial Overview
12.3.5.SWOT Analysis
12.3.6.Key Developments
12.4.CIPLA
12.4.1.Key Facts
12.4.2.Business Description
12.4.3.Products and Services
12.4.4.Financial Overview
12.4.5.SWOT Analysis
12.4.6.Key Developments
12.5.MERCK & CO.,INC.
12.5.1.Key Facts
12.5.2.Business Description
12.5.3.Products and Services
12.5.4.Financial Overview
12.5.5.SWOT Analysis
12.5.6.Key Developments
12.6.SUMITOMO CORPORATION
12.6.1.Key Facts
12.6.2.Business Description
12.6.3.Products and Services
12.6.4.Financial Overview
12.6.5.SWOT Analysis
12.6.6.Key Developments
12.7.JOHNSON AND JOHNSON
12.7.1.Key Facts
12.7.2.Business Description
12.7.3.Products and Services
12.7.4.Financial Overview
12.7.5.SWOT Analysis
12.7.6.Key Developments
12.8.PFIZER INC.
12.8.1.Key Facts
12.8.2.Business Description
12.8.3.Products and Services
12.8.4.Financial Overview
12.8.5.SWOT Analysis
12.8.6.Key Developments
12.9.SANOFI
12.9.1.Key Facts
12.9.2.Business Description
12.9.3.Products and Services
12.9.4.Financial Overview
12.9.5.SWOT Analysis
12.9.6.Key Developments
12.10.ABBOTT LABORATORIES
12.10.1.Key Facts
12.10.2.Business Description
12.10.3.Products and Services
12.10.4.Financial Overview
12.10.5.SWOT Analysis
12.10.6.Key Developments
13.APPENDIX
13.1.ABOUT THE INSIGHT PARTNERS
13.2.GLOSSARY OF TERMS
1. GlaxoSmithKline plc
2. Novartis
3. AstraZeneca
4. Cipla
5. Merck & Co., Inc.
6. Sumitomo Corporation
7. Johnson and Johnson
8. Pfizer Inc.
9. Sanofi
10. Abbott Laboratories
11. Bausch and Lomb
12. Novartis
13. Alcon
14. Merck
15. Aerosol
16. Adcock Ingram
17. Endo International
18. TARO
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For